About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
(C) 2024 MINKABU THE INFONOID, Inc.

Healthcare & Medical Investment(3455) Financial Results

3455
TSE REIT
Healthcare & Medical Investment
103,700
JPY
+100
(+0.10%)
Dec 23, 3:30 pm JST
662.19
USD
Dec 23, 1:30 am EST
Result
ー
PTS
outside of trading hours
ー
ー
Summary Chart Historical News Financial Result
Current Period Guidance
Annual
Result
Guidance History
Growth Rate
Profitability
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jan, 2023 2,632 1,453 1,279 1,278 3,555.0 3,557 Mar 17, 2023 J-GAAP
Jul, 2023 2,438 1,268 1,068 1,068 2,970.0 3,282 Sep 15, 2023 J-GAAP
Jan, 2024 2,438 1,254 1,050 1,049 2,919.0 3,235 Mar 19, 2024 J-GAAP
Jul, 2024 2,514 1,298 1,055 1,054 2,934.0 3,261 Sep 13, 2024 J-GAAP
Jan, 2025 Guidance 2,515 1,272 1,023 1,022 2,842.8 3,175 Sep 13, 2024 J-GAAP
YoY +0.0% -2.0% -3.0% -3.0% -3.1%
All-Time High
Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS
Record 2,632 1,453 1,279 1,278 3,555.0
Fiscal Year Jan, 2023 Jan, 2023 Jan, 2023 Jan, 2023 Jan, 2023
Cash Flow
Annual
Fiscal Year Operating Profit Fee Cash Flow Operating Cash Flow Investing Cash Flow Financial Cash Flow Cash & Equivalents Cash Ratio Accounting Standards
Jul, 2023 1,268 1,317 1,501 -184 -1,280 1,680 2.08 J-GAAP
Jan, 2024 1,254 1,579 1,785 -206 -1,285 1,974 2.45 J-GAAP
Jul, 2024 1,298 -1,076 1,704 -2,780 1,236 2,135 2.56 J-GAAP
Actual Performance and Financial Trends
All-Time High Quarterly Results
Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS
Record － － － － －
Fiscal Year － － － － －
Key Balance Sheet Figures
Fiscal Year BPS Equity Ratio Total Asset Equity Retained Earnings Interest-Bearing Debt Ratio Announce Accounting Standards
Jul, 2023 107,421.00 47.8 80,789 38,617 1,068 0.96 Sep 15, 2023 J-GAAP
Jan, 2024 107,196.00 47.7 80,714 38,536 1,100 0.96 Mar 19, 2024 J-GAAP
Jul, 2024 107,510.00 46.3 83,456 38,649 1,056 1.03 Sep 13, 2024 J-GAAP